Fee deals: What the past can teach us now Editorial: Of 50 years, tablets and MD advisers Medicare changes doctors Opinion: Time for improved transparency and openness in pharmaceutical drug regulation Senate report calls for more transparency and openness. The lure of ‘integrative medicine’ Why we need to practise patient engagement in a meaningful way Patients, every drug has side effects But do the benefits outweigh the potential risks? If I had a million dollars, could I buy care? Supreme Court decision: Is it right to eliminate suffering? Double-failing on health: Why it is critical we learn from past mistakes First Previous 402 403 404 405 406 Next Last
